Abstract
A significant increase of cerebral microbleeds (CMBs) was demonstrated in patients with acromegaly, which may be a result of obstructive sleep apnea (OSA) in acromegaly. The present study indicated that increasing CMBs are responsible for cognitive decline in patients with acromegaly.
Introduction
Acromegaly is a rare hormonal disorder caused by a pituitary tumor secreting excess growth hormone (GH). While its physical symptoms—such as enlarged extremities and facial features—are well-documented, the cognitive toll of the disease has only recently become a focus of clinical investigation. Patients often experience declines in memory and executive function, but the underlying structural causes have remained elusive.
Recent research suggests that cerebral microbleeds (CMBs), small circular lesions indicative of microvascular injury, may be the "smoking gun" behind this cognitive impairment. This study investigates the prevalence of CMBs in acromegaly patients and explores how comorbidities like obstructive sleep apnea (OSA) drive their formation.
Methods
The study utilized a retrospective cohort design, comparing 55 patients with acromegaly against 70 healthy controls (HC). Key technical approaches included:
- Neuroimaging: High-resolution 3.0-T MRI with Susceptibility-Weighted Imaging (SWI) was used to detect hemosiderin deposits from tiny hemorrhages.
- Rating and Assessment: CMBs were categorized using the Microbleed Anatomical Rating Scale (MARS). Cognitive performance was measured via the Montreal Cognitive Assessment (MoCA).
- Sleep Analysis: OSA was diagnosed and graded based on the American Academy of Sleep Medicine (AASM) criteria.
- Statistical Modeling: Binary logistic regression isolated CMBs as an independent risk factor, adjusting for age, education, BMI, and other comorbidities.
Key Results and Insights
The Prevalence Gap and Cognitive Impact
CMBs were found in 29.1% of acromegaly patients compared to only 5.3% of healthy controls ($p < 0.01$). Correspondingly, acromegaly patients scored significantly lower on MoCA tests (average 23.20) than controls (average 27.73). Statistical analysis showed that the presence of CMBs makes a patient 3.19 times more likely to suffer from cognitive impairment.
The "Young Brain" Paradox and OSA
A striking finding was that acromegaly patients with CMBs were significantly younger than healthy controls with similar lesions. This suggests that the hormonal imbalance of acromegaly may cause "accelerated aging" of the cerebral vasculature.
Furthermore, OSA was identified as the strongest predictor for the occurrence of microbleeds, with an Odds Ratio of 13.34. The intermittent hypoxia and blood pressure spikes associated with OSA in acromegaly patients appear to be primary drivers of small vessel damage in the brain.
Unique Pathological Distribution
Most CMBs in acromegaly patients (87.5%) were found in the lobar regions. This distribution differs from the typical deep-brain distribution seen in standard hypertensive patients, hinting at a unique pathological pathway specific to acromegaly.
Limitations and Future Directions
The study's retrospective nature and relatively small sample size (55 patients) mean that while the correlation is strong, definitive causality requires further longitudinal study. Future research will focus on whether early treatment of OSA in acromegaly patients can prevent the formation of CMBs and preserve long-term cognitive function.
Summary updated